NEW YORK, Jan. 30, 2023 /PRNewswire/ -- North America will account for 35% of the global Interstitial cystitis (IC) drugs market growth. The increasing cases of interstitial cystitis and the rise in research funding are driving the growth of the regional market. The Interstitial Cystitis Drugs Market by Type, Distribution Channel, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 5.9% and register an incremental growth of USD 369.58 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market.
Download a PDF Sample Report
Technavio has announced its latest market research report titled Global Interstitial Cystitis Drugs Market The interstitial cystitis (IC) drugs market report includes information on the key products and recent developments of leading vendors, including: To gain access to more vendor profiles available with Technavio,
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others.
By type, the market is segmented into
oral therapy and intravesical therapy. The
oral therapy segment accounted for the largest share of the market.
By geography, the market is segmented into
North America, Europe, Asia, and Rest of World (ROW).
North America held the largest share of the market.
CAGR of 6.09% between 2022 and 2027. The size of the market is forecast to increase by
USD 6,654.49 million. The rising prevalence of COPD is notably driving the market growth, although factors such as the high cost of conducting clinical trials in COPD may impede the market growth. Allergy Immunotherapies Market by Product, Type, and Geography - Forecast and Analysis 2023-2027: The allergy immunotherapies market is estimated to grow at a CAGR of 8.95% between 2022 and 2027. The size of the market is forecast to increase by
USD 1,010.37 million. The increasing prevalence of allergies is notably driving the market growth, although factors such as trial failures may impede the market growth. Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies.
Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights
CAGR of the market during the forecast period
Precise estimation of the size of interstitial cystitis (IC) drugs market and its contribution to the parent market Accurate predictions about upcoming trends and changes in consumer behavior
A thorough analysis of the market's competitive landscape and detailed information about vendors
Browse for Technavio "Health Care" Research Reports
Exhibit 01: Parent market
Exhibit 02: Market characteristics
Exhibit 03: Value chain analysis: Pharmaceuticals
Exhibit 04: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 05: Market segments
3.4 Market outlook: Forecast for 2020 - 2025
Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibit 08: Five forces analysis 2020 & 2025
4.2 Bargaining power of buyers
Exhibit 09: Bargaining power of buyers
4.3 Bargaining power of suppliers
Exhibit 10: Bargaining power of suppliers
4.4 Threat of new entrants
Exhibit 11: Threat of new entrants
4.5 Threat of substitutes
Exhibit 12: Threat of substitutes
Exhibit 13: Threat of rivalry
Exhibit 14: Market condition - Five forces 2020
5 Market Segmentation by Type
Exhibit 15: Type - Market share 2020-2025 (%)
Exhibit 16: Comparison by Type
5.3 Oral therapy - Market size and forecast 2020-2025
Exhibit 17: Oral therapy - Market size and forecast 2020-2025 ($ million)
Exhibit 18: Oral therapy - Year-over-year growth 2020-2025 (%)
5.4 Intravesical therapy - Market size and forecast 2020-2025
Exhibit 19: Intravesical therapy - Market size and forecast 2020-2025 ($ million)
Exhibit 20: Intravesical therapy - Year-over-year growth 2020-2025 (%)
5.5 Market opportunity by Type
Exhibit 21: Market opportunity by Type
7.1 Geographic segmentation
Exhibit 23: Market share by geography 2020-2025 (%)
7.2 Geographic comparison
Exhibit 24: Geographic comparison
7.3 North America - Market size and forecast 2020-2025
Exhibit 25: North America - Market size and forecast 2020-2025 ($ million)
Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
7.4 Europe - Market size and forecast 2020-2025
Exhibit 27: Europe - Market size and forecast 2020-2025 ($ million)
Exhibit 28: Europe - Year-over-year growth 2020-2025 (%)
7.5 Asia - Market size and forecast 2020-2025
Exhibit 29: Asia - Market size and forecast 2020-2025 ($ million)
Exhibit 30: Asia - Year-over-year growth 2020-2025 (%)
7.6 ROW - Market size and forecast 2020-2025
Exhibit 31: ROW - Market size and forecast 2020-2025 ($ million)
Exhibit 32: ROW - Year-over-year growth 2020-2025 (%)
7.7 Key leading countries
Exhibit 33: Key leading countries
7.8 Market opportunity by geography
Exhibit 34: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
Exhibit 35: Impact of drivers and challenges
Exhibit 36: Vendor landscape
Exhibit 37: Landscape disruption
Exhibit 38: Industry risks
Exhibit 39: Vendors covered
10.2 Market positioning of vendors
Exhibit 40: Market positioning of vendors
Exhibit 46: Bayer AG - Business segments 11.2 Currency conversion rates for US$
Exhibit 85: Currency conversion rates for US$
11.3 Research methodology
Exhibit 86: Research Methodology
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: Information sources
11.4 List of abbreviations
Exhibit 89: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
Website: www.technavio.com/